Status:
COMPLETED
Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Blood Loss
Eligibility:
All Genders
18+ years
Brief Summary
Perioperative variables that can be used to create a bundled approach quality improvement protocol to minimize blood loss in spine surgery will be evaluated using retrospective data collection and mul...
Detailed Description
Blood loss is a major concern in spine surgery. Within lumbar fusion surgery, one study estimated an average blood loss of 800 mL (range 100-3,100 mL) for non-instrumented fusion and 1,517 mL (range 3...
Eligibility Criteria
Inclusion
- Age 18 or older
- Undergoing lumbar spine surgery
- Surgery performed between July 1, 2016 and November 30, 2018
- Surgery performed at the Johns Hopkins East Baltimore Campus
- Available data on hemostatic agents used
Exclusion
- Age under 18
- Surgery at location other than lumbar spine
- Surgical details unavailable
- Data unavailable for specified endpoints, including:
- Hemostatic agent use
- Blood loss
- Operative time
Key Trial Info
Start Date :
June 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04058665
Start Date
June 18 2019
End Date
March 1 2022
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21287